Evidence map›Paper›PMID 32498223›Full record

ArticleJournal of clinical medicine2020

Functional Heterogeneity of Mouse and Human Brain OPCs: Relevance for Preclinical Studies in Multiple Sclerosis.

Ana Bribián, Eva M Medina-Rodríguez, Fernando Josa-Prado, Isabel García-Álvarez, Isabel Machín-Díaz, Pedro F Esteban, Verónica Murcia-Belmonte, Lorena Vega-Zelaya, Jesús Pastor, Leoncio Garrido and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. The Current Challenges for Drug Discovery in CNS Remyelination.International journal of molecular sciences · 2021
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Ana BribiánInstituto Cajal-CSIC, CSIC, Avda. Dr. Arce 37, 28002 Madrid, Spain.
Eva M Medina-RodríguezGrupo de Neurobiología del Desarrollo-GNDe, Hospital Nacional de Parapléjicos, Finca "La Peraleda" s/n, 45071 Toledo, Spain.
Fernando Josa-PradoInstituto Cajal-CSIC, CSIC, Avda. Dr. Arce 37, 28002 Madrid, Spain.ORCID 0000-0002-6162-3231
Isabel García-ÁlvarezFacultad de Ciencias Experimentales, Universidad Francisco de Vitoria, Ctra. Pozuelo-Majadahonda Km 1800, Pozuelo de Alarcón, 28223 Madrid, Spain.ORCID 0000-0002-2273-5046
Isabel Machín-DíazGrupo de Neurobiología del Desarrollo-GNDe, Hospital Nacional de Parapléjicos, Finca "La Peraleda" s/n, 45071 Toledo, Spain.
Pedro F EstebanGrupo de Neurobiología del Desarrollo-GNDe, Hospital Nacional de Parapléjicos, Finca "La Peraleda" s/n, 45071 Toledo, Spain.
Verónica Murcia-BelmonteGrupo de Neurobiología del Desarrollo-GNDe, Hospital Nacional de Parapléjicos, Finca "La Peraleda" s/n, 45071 Toledo, Spain.ORCID 0000-0001-5588-7057
Lorena Vega-ZelayaNeurofisiología Clínica; Instituto de Investigación Sanitaria, Hospital Universitario de la Princesa, 28006 Madrid, Spain.
Jesús PastorNeurofisiología Clínica; Instituto de Investigación Sanitaria, Hospital Universitario de la Princesa, 28006 Madrid, Spain.ORCID 0000-0001-6870-8409
Leoncio GarridoInstituto de Ciencia y Tecnología de Polímeros (ICTP-CSIC), CSIC, Juan de la Cierva 3, 28006 Madrid, Spain.ORCID 0000-0002-7587-1260
Fernando de CastroInstituto Cajal-CSIC, CSIC, Avda. Dr. Arce 37, 28002 Madrid, Spain.ORCID 0000-0002-7018-8032
Hospital Nacional de Parapléjicos · ESInstituto Cajal · ESHospital Universitario de La Princesa · ESInstituto de Ciencia y Tecnología de Polímeros · ESUniversidad Francisco de Vitoria · ES

Funding

Consejo Superior de Investigaciones Científicas PID2019-109858RB-100Fundación Eugenio Rodríguez Pascual -Fundación Ramón Areces CIVP19A5917Ministerio de Ciencia e Innovación SAF2009-07842, ADE10-0010, SAF2012-40023, SAF2016-77575-RRed Española de Esclerosis Múltiple RD12-0032-12; RD16/0015/0019
6 · The paper itself

Abstract

Besides giving rise to oligodendrocytes (the only myelin-forming cell in the Central Nervous System (CNS) in physiological conditions), Oligodendrocyte Precursor Cells (OPCs) are responsible for spontaneous remyelination after a demyelinating lesion. They are present along the mouse and human CNS, both during development and in adulthood, yet how OPC physiological behavior is modified throughout life is not fully understood. The activity of adult human OPCs is still particularly unexplored. Significantly, most of the molecules involved in OPC-mediated remyelination are also involved in their development, a phenomenon that may be clinically relevant. In the present article, we have compared the intrinsic properties of OPCs isolated from the cerebral cortex of neonatal, postnatal and adult mice, as well as those recovered from neurosurgical adult human cerebral cortex tissue. By analyzing intact OPCs for the first time with 1H High Resolution Magic Angle Spinning Nuclear Magnetic Resonance (1H HR-MAS NMR) spectroscopy, we show that these cells behave distinctly and that they have different metabolic patterns in function for their stage of maturity. Moreover, their response to Fibroblast Growth Gactor-2 (FGF-2) and anosmin-1 (two molecules that have known effects on OPC biology during development and that are overexpressed in individuals with Multiple Sclerosis (MS)) differs in relation to their developmental stage and in the function of the species. Our data reveal that the behavior of adult human and mouse OPCs differs in a very dynamic way that should be very relevant when testing drugs and for the proper design of effective pharmacological and/or cell therapies for MS.

Indexed as

demyelinationhumanleukodystrophiesmultiple sclerosismyelinoligodendrocyteremyelination

Identifiers

PMID32498223
PMCPMC7355819
OpenAlexW3032079073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.